Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers-Reference-Cited by-同舟云学术

Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers

Published:2021-01-26 Issue:3 Volume:41 Page:545-553
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Hagström Hannes¹²³^ORCID,Ndegwa Nelson⁴⁵^ORCID,Jalmeus Molly³,Ekstedt Mattias⁶,Posserud Iris⁷,Rorsman Fredrik⁸,Nyhlin Nils⁹,Klintman Daniel¹⁰,Werner Mårten¹¹,Marschall Hanns‐Ulrich¹²^ORCID,Askling Johan²,Stål Per¹³,

Affiliation:

1. Division of Hepatology Department of Upper GI diseases Karolinska University Hospital Stockholm Sweden

2. Clinical Epidemiology Division Department of Medicine, Solna Karolinska Institutet Stockholm Sweden

3. Department of Medicine, Huddinge Karolinska Institutet Stockholm Sweden

4. Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden

5. Division of Surgery Department of Clinical Science Intervention and Technology Karolinska Institutet, and Oesophageal and Gastric Cancer Unit Karolinska University Hospital Stockholm Sweden

6. Division of Diagnostics and Specialist Medicine Department of Health, Medicine and Caring Sciences Linköping University Linköping Sweden

7. Department of Internal Medicine and Clinical Nutrition Institute of Medicine Sahlgrenska AcademyUniversity of Gothenburg Gothenburg Sweden

8. Department of Gastroenterology and Hepatology Uppsala University Hospital Uppsala Sweden

9. Department of Gastroenterology Faculty of Medicine and Health Örebro University Örebro Sweden

10. Department of Gastroenterology and Hepatology Skåne University Hospital, Malmö Sweden

11. Department of Public Health and Clinical Medicine, Medicine Umeå University Umeå Sweden

12. Department of Molecular and Clinical Medicine Sahlgrenska AcademyUniversity of Gothenburg Gothenburg Sweden

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14792

Reference37 articles.

1. Geography ofHFEC282Y and H63D Mutations

2. Haemochromatosis

3. EASL clinical practice guidelines for HFE hemochromatosis

4. Haemochromatosis

5. Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: A rare case of hereditary hemochromatosis caused by a mutation in the HAMP gene in Fuyang, China;Frontiers in Medicine;2024-06-28

3. HFEgenotypes, haemochromatosis diagnosis and clinical outcomes at age 80 years: a prospective cohort study in the UK Biobank;BMJ Open;2024-03

4. The Impact of Blood Glucose and Antidiabetic Medications on Osteoarthritis: A Mendelian Randomization Study;2024-03-01

5. Serum ferritin level is associated with liver fibrosis and incident liver-related outcomes independent of HFE genotype in the general population;Scandinavian Journal of Gastroenterology;2024-02-08